Bloomberg Law
Pharmaceutical & Life Sciences News

Latest Stories

Fate Therapeutics Leaders Misrepresented J&J Tie, Investor Says

Fate Therapeutics Inc.'s executives and directors harmed the drugmaker when they overstated the viability of its partnership with the Johnson & Johnson unit Janssen Biotech Inc. in public statements and filings, an investor says in a new derivative suit.

Former Amgen Employee Loses Attempt to Reinstate Takings Claim

A former Amgen Inc. employee who contends that he helped the US government reach a lucrative False Claims Act settlement with the biopharmaceutical company lost a bid to revive his claim that the government made an unlawful taking under the Fifth Amendment, the Federal Circuit said Tuesday.

Merck Sues US, Calling Move to Cut Drug Prices ‘Extortion’

Merck & Co. is suing the US over a law that will allow the government to negotiate prescription-drug prices with pharmaceutical companies — a reform aimed at cutting costs for elderly and disabled Medicare patients that the health-care giant says is “tantamount to extortion.”

Disney-DeSantis Feud Recusal a Possible Reply to Supreme Court

Attorneys and legal scholars say it’s understandable why Judge Mark Walker erred on the side of caution and stepped down from litigation between Walt Disney Parks and Resorts US Inc. and Florida Gov. Ron DeSantis. Some say his order could even be read as a direct response to ethical issues dogging the US Supreme Court.